Development and Validation Features of the Patient Benefit Index for the Treatment of Allergic Rhinoconjunctivitis with Allergen Immunotherapy.
Anna K LangenbruchWüstenberg EikeHendrik WolfMatthias AugustinPublished in: Journal of asthma and allergy (2022)
The results indicate feasibility, reliability, convergent and discriminant validity as well as sensitivity to change of the PBI-AIT.